371 related articles for article (PubMed ID: 20610621)
1. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.
Xia N; Daiber A; Habermeier A; Closs EI; Thum T; Spanier G; Lu Q; Oelze M; Torzewski M; Lackner KJ; Münzel T; Förstermann U; Li H
J Pharmacol Exp Ther; 2010 Oct; 335(1):149-54. PubMed ID: 20610621
[TBL] [Abstract][Full Text] [Related]
2. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
[TBL] [Abstract][Full Text] [Related]
3. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926.
Zhou ZW; Xie XL; Zhou SF; Li CG
Eur J Pharmacol; 2012 Dec; 697(1-3):97-105. PubMed ID: 23063542
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats.
Bhatt SR; Lokhandwala MF; Banday AA
Eur J Pharmacol; 2011 Sep; 667(1-3):258-64. PubMed ID: 21640096
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice.
d'Uscio LV; Smith LA; Katusic ZS
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2227-34. PubMed ID: 21963838
[TBL] [Abstract][Full Text] [Related]
8. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
10. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.
Zhu M; Chen J; Tan Z; Wang J
Anesth Analg; 2012 Feb; 114(2):303-9. PubMed ID: 22156331
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension.
Cervantes-Pérez LG; Ibarra-Lara Mde L; Escalante B; Del Valle-Mondragón L; Vargas-Robles H; Pérez-Severiano F; Pastelín G; Sánchez-Mendoza MA
Eur J Pharmacol; 2012 Jun; 685(1-3):108-15. PubMed ID: 22542661
[TBL] [Abstract][Full Text] [Related]
13. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression.
Crabtree MJ; Tatham AL; Al-Wakeel Y; Warrick N; Hale AB; Cai S; Channon KM; Alp NJ
J Biol Chem; 2009 Jan; 284(2):1136-44. PubMed ID: 19011239
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.
Singh U; Devaraj S; Vasquez-Vivar J; Jialal I
J Mol Cell Cardiol; 2007 Dec; 43(6):780-91. PubMed ID: 17942113
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice.
Santhanam AV; d'Uscio LV; He T; Das P; Younkin SG; Katusic ZS
J Neurochem; 2015 Sep; 134(6):1129-38. PubMed ID: 26111938
[TBL] [Abstract][Full Text] [Related]
16. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
Ding H; Hashem M; Triggle C
Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
[TBL] [Abstract][Full Text] [Related]
17. GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP.
Kumar S; Sun X; Sharma S; Aggarwal S; Ravi K; Fineman JR; Black SM
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L309-17. PubMed ID: 19447893
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling of eNOS contributes to redox-sensitive leukocyte recruitment and microvascular leakage elicited by methylglyoxal.
Su Y; Qadri SM; Hossain M; Wu L; Liu L
Biochem Pharmacol; 2013 Dec; 86(12):1762-74. PubMed ID: 24144633
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression.
Alp NJ; Mussa S; Khoo J; Cai S; Guzik T; Jefferson A; Goh N; Rockett KA; Channon KM
J Clin Invest; 2003 Sep; 112(5):725-35. PubMed ID: 12952921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
